Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 820

1.

Clozapine and olanzapine are associated with food craving and binge eating: results from a randomized double-blind study.

Kluge M, Schuld A, Himmerich H, Dalal M, Schacht A, Wehmeier PM, Hinze-Selch D, Kraus T, Dittmann RW, Pollmächer T.

J Clin Psychopharmacol. 2007 Dec;27(6):662-6.

PMID:
18004133
[PubMed - indexed for MEDLINE]
2.
3.

Childhood-onset schizophrenia: A double-blind, randomized clozapine-olanzapine comparison.

Shaw P, Sporn A, Gogtay N, Overman GP, Greenstein D, Gochman P, Tossell JW, Lenane M, Rapoport JL.

Arch Gen Psychiatry. 2006 Jul;63(7):721-30.

PMID:
16818861
[PubMed - indexed for MEDLINE]
4.

[Prescription of olanzapine in children and adolescent psychiatric patients].

Frémaux T, Reymann JM, Chevreuil C, Bentué-Ferrer D.

Encephale. 2007 Mar-Apr;33(2):188-96. Review. French.

PMID:
17675914
[PubMed - indexed for MEDLINE]
5.

Effects of clozapine and olanzapine on cytokine systems are closely linked to weight gain and drug-induced fever.

Kluge M, Schuld A, Schacht A, Himmerich H, Dalal MA, Wehmeier PM, Hinze-Selch D, Kraus T, Dittmann RW, Pollmächer T.

Psychoneuroendocrinology. 2009 Jan;34(1):118-28. doi: 10.1016/j.psyneuen.2008.08.016. Epub 2008 Oct 4.

PMID:
18835660
[PubMed - indexed for MEDLINE]
6.

A randomized, double-blind comparison of clozapine and high-dose olanzapine in treatment-resistant patients with schizophrenia.

Meltzer HY, Bobo WV, Roy A, Jayathilake K, Chen Y, Ertugrul A, Anil Yağcioğlu AE, Small JG.

J Clin Psychiatry. 2008 Feb;69(2):274-85.

PMID:
18232726
[PubMed - indexed for MEDLINE]
7.

Standard and higher dose of olanzapine in patients with schizophrenia or schizoaffective disorder: a randomized, double-blind, fixed-dose study.

Kinon BJ, Volavka J, Stauffer V, Edwards SE, Liu-Seifert H, Chen L, Adams DH, Lindenmayer JP, McEvoy JP, Buckley PF, Lieberman JA, Meltzer HY, Wilson DR, Citrome L.

J Clin Psychopharmacol. 2008 Aug;28(4):392-400. doi: 10.1097/JCP.0b013e31817e63a5.

PMID:
18626265
[PubMed - indexed for MEDLINE]
8.

Clozapine, olanzapine, risperidone, and haloperidol in the treatment of patients with chronic schizophrenia and schizoaffective disorder.

Volavka J, Czobor P, Sheitman B, Lindenmayer JP, Citrome L, McEvoy JP, Cooper TB, Chakos M, Lieberman JA.

Am J Psychiatry. 2002 Feb;159(2):255-62. Erratum in: Am J Psychiatry 2002 Dec;159(12):2132.

PMID:
11823268
[PubMed - indexed for MEDLINE]
9.

Changes in glucose and cholesterol levels in patients with schizophrenia treated with typical or atypical antipsychotics.

Lindenmayer JP, Czobor P, Volavka J, Citrome L, Sheitman B, McEvoy JP, Cooper TB, Chakos M, Lieberman JA.

Am J Psychiatry. 2003 Feb;160(2):290-6.

PMID:
12562575
[PubMed - indexed for MEDLINE]
10.

Adverse effects and laboratory parameters of high-dose olanzapine vs. clozapine in treatment-resistant schizophrenia.

Kelly DL, Conley RR, Richardson CM, Tamminga CA, Carpenter WT Jr.

Ann Clin Psychiatry. 2003 Sep-Dec;15(3-4):181-6.

PMID:
14971863
[PubMed - indexed for MEDLINE]
11.

Olanzapine versus clozapine in treatment-resistant or treatment-intolerant schizophrenia.

Bitter I, Dossenbach MR, Brook S, Feldman PD, Metcalfe S, Gagiano CA, Füredi J, Bartko G, Janka Z, Banki CM, Kovacs G, Breier A; Olanzapine HGCK Study Group.

Prog Neuropsychopharmacol Biol Psychiatry. 2004 Jan;28(1):173-80.

PMID:
14687871
[PubMed - indexed for MEDLINE]
12.

Double-blind, randomized comparison of olanzapine versus fluphenazine in the long-term treatment of schizophrenia.

Dossenbach MR, Folnegovic-Smalc V, Hotujac L, Uglesic B, Tollefson GD, Grundy SL, Friedel P, Jakovljevic MM; Olanzapine HGCH Study Group.

Prog Neuropsychopharmacol Biol Psychiatry. 2004 Mar;28(2):311-8.

PMID:
14751428
[PubMed - indexed for MEDLINE]
13.

Clozapine and "high-dose" olanzapine in refractory early-onset schizophrenia: a 12-week randomized and double-blind comparison.

Kumra S, Kranzler H, Gerbino-Rosen G, Kester HM, De Thomas C, Kafantaris V, Correll CU, Kane JM.

Biol Psychiatry. 2008 Mar 1;63(5):524-9. Epub 2007 Jul 25.

PMID:
17651705
[PubMed - indexed for MEDLINE]
14.

Objective and subjective efficacy as well as tolerability of olanzapine in the acute treatment of 120 patients with schizophrenia spectrum disorders.

Lambert M, Holzbach R, Moritz S, Postel N, Krausz M, Naber D.

Int Clin Psychopharmacol. 2003 Sep;18(5):251-60.

PMID:
12920385
[PubMed - indexed for MEDLINE]
15.

Factors influencing acute weight change in patients with schizophrenia treated with olanzapine, haloperidol, or risperidone.

Basson BR, Kinon BJ, Taylor CC, Szymanski KA, Gilmore JA, Tollefson GD.

J Clin Psychiatry. 2001 Apr;62(4):231-8.

PMID:
11379836
[PubMed - indexed for MEDLINE]
16.

Olanzapine versus lithium in the acute treatment of bipolar mania: a double-blind, randomized, controlled trial.

Niufan G, Tohen M, Qiuqing A, Fude Y, Pope E, McElroy H, Ming L, Gaohua W, Xinbao Z, Huichun L, Liang S.

J Affect Disord. 2008 Jan;105(1-3):101-8. Epub 2007 May 24.

PMID:
17531327
[PubMed - indexed for MEDLINE]
17.

[A naturalistic, observational study of outpatients with schizophrenia: efficacy and safety results after 6 months. The International Schizophrenia Outpatient Health Outcomes study, IC-SOHO].

István S, Agoston T, Tamás T, Zoltán J.

Neuropsychopharmacol Hung. 2007 Oct;9(3):115-24. Hungarian.

PMID:
18399029
[PubMed - indexed for MEDLINE]
Free Article
18.

Atypical antipsychotic agents in the treatment of violent patients with schizophrenia and schizoaffective disorder.

Krakowski MI, Czobor P, Citrome L, Bark N, Cooper TB.

Arch Gen Psychiatry. 2006 Jun;63(6):622-9.

PMID:
16754835
[PubMed - indexed for MEDLINE]
19.

A randomized, 1-year follow-up study of olanzapine and risperidone in the treatment of negative symptoms in outpatients with schizophrenia.

Alvarez E, Ciudad A, Olivares JM, Bousoño M, Gómez JC.

J Clin Psychopharmacol. 2006 Jun;26(3):238-49.

PMID:
16702888
[PubMed - indexed for MEDLINE]
20.

A 24-week randomized study of olanzapine versus ziprasidone in the treatment of schizophrenia or schizoaffective disorder in patients with prominent depressive symptoms.

Kinon BJ, Lipkovich I, Edwards SB, Adams DH, Ascher-Svanum H, Siris SG.

J Clin Psychopharmacol. 2006 Apr;26(2):157-62.

PMID:
16633144
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk